Literature DB >> 17333446

Beta-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study.

C Meisinger1, M Heier, O Lang, A Döring.   

Abstract

UNLABELLED: Use of beta-blockers is associated with a reduced risk of fractures in middle-aged and older subjects from the general population.
INTRODUCTION: The present prospective population-based study investigated the association between use of beta-blockers and incidence of any fracture.
METHODS: The study was based on 1,793 persons 55 to 74 years of age who participated in one of the three MONICA Augsburg surveys between 1984 and 1995. Subjects were without any fracture at baseline. Incident fractures were assessed using a health questionnaire. Hazard ratios (HRs) were estimated from Cox proportional hazard models.
RESULTS: During a mean follow-up of 10.7 years, there occurred 263 incident fractures. beta-blocker users were older, were significantly more likely to be obese, to drink no alcohol, to have hypertension or diabetes, to use thiazides and statins, and to be physically inactive. The use of beta-blockers was associated with a lower risk of any fracture (HR 0.57; 95% CI = 0.36-0.90) after adjustment for age, sex and survey. Further adjustment for body mass index and education years only slightly attenuated the relationship (HR 0.60; 95% CI = 0.38-0.95) and additional adjustment for a variety of further risk factors did not attenuate the association (HR 0.60; 95% CI = 0.37-0.96).
CONCLUSION: Use of beta-blockers was associated with a reduced risk of fractures in middle-aged and older subjects from the general population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333446     DOI: 10.1007/s00198-007-0354-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.

Authors:  Régis Levasseur; Patricia Dargent-Molina; Jean-Pierre Sabatier; Christian Marcelli; Gérard Bréart
Journal:  J Am Geriatr Soc       Date:  2005-03       Impact factor: 5.562

2.  Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats.

Authors:  E L Hill; R Turner; R Elde
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

3.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

4.  beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.

Authors:  Ian R Reid; Gregory D Gamble; Andrew B Grey; Dennis M Black; Kristine E Ensrud; Warren S Browner; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2004-12-06       Impact factor: 6.741

5.  [Nonparticipation as a factor influencing the value of follow-up studies. Results of a telephone 5-year follow-up interview of 55-74-year-old participants of the Augsburg 1989/90 MONICA Survey].

Authors:  A Baumann; J Stieber; H Löwel
Journal:  Gesundheitswesen       Date:  1997-04

6.  Validity of self-reports of fractures in perimenopausal women.

Authors:  K Honkanen; R Honkanen; L Heikkinen; H Kröger; S Saarikoski
Journal:  Am J Epidemiol       Date:  1999-09-01       Impact factor: 4.897

7.  [Validity and reliability of proband recall of fractures].

Authors:  C Meisinger; M Wildner; A Döring; O Sangha
Journal:  Soz Praventivmed       Date:  2000

8.  Effect of surgical sympathectomy on bone remodeling at rat incisor and molar root sockets.

Authors:  H S Sandhu; M S Herskovits; I J Singh
Journal:  Anat Rec       Date:  1987-09

9.  Use of beta-blockers and risk of fractures.

Authors:  Raymond G Schlienger; Marius E Kraenzlin; Susan S Jick; Christoph R Meier
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

10.  Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture.

Authors:  R E Moore; C K Smith; C S Bailey; E F Voelkel; A H Tashjian
Journal:  Bone Miner       Date:  1993-12
View more
  19 in total

Review 1.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

2.  Mice lacking beta-adrenergic receptors have increased bone mass but are not protected from deleterious skeletal effects of ovariectomy.

Authors:  M L Bouxsein; M J Devlin; V Glatt; H Dhillon; D D Pierroz; S L Ferrari
Journal:  Endocrinology       Date:  2008-09-18       Impact factor: 4.736

3.  Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial.

Authors:  Karen L Margolis; Lisa Palermo; Eric Vittinghoff; Gregory W Evans; Hal H Atkinson; Bruce P Hamilton; Robert G Josse; Patrick J O'Connor; Debra L Simmons; Margaret Tiktin; Ann V Schwartz
Journal:  J Gen Intern Med       Date:  2014-08-16       Impact factor: 5.128

4.  β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.

Authors:  K A Toulis; K Hemming; S Stergianos; K Nirantharakumar; J P Bilezikian
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

Review 5.  The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.

Authors:  Joshua I Barzilay; Barry R Davis; Sara L Pressel; Alokananda Ghosh; Rachel Puttnam; Karen L Margolis; Paul K Whelton
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 6.  Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2018-02-10       Impact factor: 3.843

7.  β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.

Authors:  Yun Ma; Jeffry S Nyman; Huan Tao; Heather H Moss; Xiangli Yang; Florent Elefteriou
Journal:  Endocrinology       Date:  2011-01-25       Impact factor: 4.736

8.  Therapeutic perspectives.

Authors:  Carmelo E Fiore; Pietra Pennisi; Marianna Tinè
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

9.  Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.

Authors:  B Abrahamsen; K Brixen
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

Review 10.  Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?

Authors:  P Anagnostis; A Karagiannis; A I Kakafika; K Tziomalos; V G Athyros; D P Mikhailidis
Journal:  Osteoporos Int       Date:  2008-05-29       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.